Catalyst Wire Dossier Catalyst Wire Dossier

Kedbumin 25%

Kedbumin · Kedrion S.p.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kedbumin 25%, covering 2021-02-18 to 2021-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric Patients [Phase 4]

See pricing